Pacertool develops the PaCRTool system to help clinicians select heart-failure patients for cardiac resynchronization therapy and optimize pacing-lead placement during pacemaker implantation. Its technology uses a cardiac electromechanical biomarker to quantify whether pacing improves synchronization, supporting an individualized approach to treatment. The Norwegian medical-device company has pursued early feasibility studies and a US regulatory-development strategy. Current product availability or regulatory clearance has not been independently established; the issuer’s published product description concerns development rather than an approved clinical product.
Founded 2019
Team
Cecilia LindeScientific Advisory Board Member (appointed October 2022; current tenure unconfirmed)
Christophe LeclercqScientific Advisory Board Member (appointed October 2022; current tenure unconfirmed)
Hans Henrik OdlandFounder; President and Chief Medical Officer (published October 2022; current executive tenure unconfirmed)
Jon H. HoemCEO (published October 2022; current tenure unconfirmed)
